The core activity of Kugelmeiers Ltd. is the development and provision of technologies and products for regenerative medicine, particularly for cell therapy and the development of 3D-spheroids for medical applications. The company focuses on creating platforms and products that enable cell therapies to be made safe, efficient and accessible to all.
AI-generated
Offering
Products & services
Industry:Medical Technology Industry
✓ Offered
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
3D cell culture technologies for research, diagnostics and regenerative medicine, for producing standardized cell spheroids and for applications usable in translational contexts.
Sphericalplate 5D®
Patented platform for controlled, scalable spheroid formation with standardized cell cultures, reproducible results and applications in research, diagnostics and therapy.
96-well Strip Format
96-well strip format for flexible experiment planning in 3D cell culture, with data collection from multiple individuals in a small volume.
Plates for 3D cell culture
24-well and 6-well plates for entry and scaling up 3D cell culture with standardized spheroid production.
Applications for diagnostics
3D spheroid models for drug screening, toxicity testing and patient-derived testing approaches for personalized medicine.
Knowledge
No knowledge articles yet
Once Kugelmeiers AG has claimed this profile, we'll publish editorial articles and case studies here together.